CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 4 of 15

Annals of the Rheumatic Diseases

Briefs 121–160 of 596 CurrentRheuma has covered from this journal, newest publication first

Latest from Annals of the Rheumatic Diseases

All coverage, newest first

  1. Ann Rheum Dis

    Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case series

    Cohort studySystemic sclerosis

  2. Ann Rheum Dis

    How long do people with rheumatic and musculoskeletal diseases stay healthy and in work across Europe? Analysis of data from SHARE and ELSA

    Cohort studyAcross diseases

  3. Ann Rheum Dis

    Psoriatic dactylitis: the association with HLA genetic susceptibility markers

    Cohort studySpondyloarthritis & PsA

  4. Ann Rheum Dis

    Progression from at-risk state to clinical and severe systemic lupus erythematosus involves molecular dysregulations potentially reversible by biologics: implications for early diagnosis and treatment

    Cohort studyLupus & APS

  5. Ann Rheum Dis

    Spacing of a TNF inhibitor or dose reduction of methotrexate vs continued treatment in patients with rheumatoid arthritis in remission or low disease activity: a randomised, controlled trial (SORAIRO trial)

    Randomized controlled trialRA

  6. Ann Rheum Dis

    Microbial signatures in psoriatic arthritis distinguish disease phenotypes and newly diagnosed inflammatory bowel disease independent of faecal calprotectin

    Cross-sectional studySpondyloarthritis & PsA

  7. Ann Rheum Dis

    The epigenomic landscape of primary tissues in osteoarthritis

    Mechanistic studyOsteoarthritis

  8. Ann Rheum Dis

    Efficacy and safety of mufemilast in patients with Behçet’s syndrome: a phase 2 randomised clinical trial

    Randomized controlled trialVasculitis & PMR

  9. Ann Rheum Dis

    A phase 2, randomised, placebo-controlled study of guselkumab in adults with new-onset or relapsing giant cell arteritis

    Randomized controlled trialVasculitis & PMR

  10. Ann Rheum Dis

    Safety and immunogenicity of the recombinant zoster vaccine in patients with rheumatoid arthritis using abatacept: a pilot multicentre, double-blind, randomised controlled trial

    Randomized controlled trialRA

  11. Ann Rheum Dis

    Heterogeneous responses of IM19 anti-CD19 CAR T-cell therapy in refractory systemic lupus erythematosus: an open-label pilot study and a mini-review

    Research articleLupus & APS

  12. Ann Rheum Dis

    Gain of function NOTCH4 variants disrupt angiogenesis in systemic sclerosis

    Mechanistic studySystemic sclerosis

  13. Ann Rheum Dis

    Intra-articular injection of autologous tolerogenic dendritic cells modifies the synovial immune landscape in rheumatoid and inflammatory arthritis

    Mechanistic studyRA

  14. Ann Rheum Dis

    Successful discontinuation of oral glucocorticoids after short-term bridging therapy in patients with newly diagnosed rheumatoid arthritis

    Secondary analysisRA

  15. Ann Rheum Dis

    CD40-CD40L inhibition attenuates platelet-neutrophil interaction and neutrophil extracellular trap release in primary antiphospholipid syndrome

    Mechanistic studyLupus & APS

  16. Ann Rheum Dis

    The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133)

    Cohort studySystemic sclerosis

  17. Ann Rheum Dis

    Type I interferon endotypes drive divergent clinical trajectories in childhood-onset SLE uncovered through a novel systems immunology approach

    Mechanistic studyPediatric

  18. Ann Rheum Dis

    A genetic variant of BAFF is associated with the risk of lymphoma in Sjögren disease

    Case-control studySjögren's & overlap

  19. Ann Rheum Dis

    Untargeted breathomics identifies metabolic signatures of immune activity, intestinal integrity, and fatigue in systemic lupus erythematosus

    Cross-sectional studyLupus & APS

  20. Ann Rheum Dis

    Treatment nonresponders in lupus nephritis characteristically exhibit persistent type I interferon signalling in monocytes: a longitudinal single-cell transcriptomic analysis

    Mechanistic studyLupus & APS

  21. Ann Rheum Dis

    Altered AP-1, RUNX, and EGR chromatin dynamics drive human fibrotic lung disease

    Mechanistic studySystemic sclerosis

  22. Ann Rheum Dis

    Inflammation rather than anticitrullinated protein antibodies is associated with cardiovascular mortality in RA: insights from rheumatoid arthritis and coronary artery disease cohorts

    Cohort studyRA

  23. Ann Rheum Dis

    Evaluation of the placebo and treatment effect overtime in randomised clinical trials evaluating the efficacy of biologics in axial spondyloarthritis: systematic review and meta-analysis

    Meta-analysisSpondyloarthritis & PsA

  24. Ann Rheum Dis

    Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren’s disease

    Secondary analysisSjögren's & overlap

  25. Ann Rheum Dis

    Results of a 1-year randomised double-blind placebo-controlled trial with methotrexate 25 mg/week in recently diagnosed polymyalgia rheumatica

    Randomized controlled trialVasculitis & PMR

  26. Ann Rheum Dis

    Shared and unique molecular signatures across different autoantibody groups in systemic sclerosis: a multiomics analysis

    Mechanistic studySystemic sclerosis

  27. Ann Rheum Dis

    Development and validation of a model to predict the disease activity score: towards a remote treat-to-target approach for rheumatoid arthritis

    Diagnostic or prognostic studyRA

  28. Ann Rheum Dis

    Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality

    Cohort studyLupus & APS

  29. Ann Rheum Dis

    Th9-arterial endothelial cell crosstalk promotes psoriatic atherosclerosis

    Mechanistic studyAcross diseases

  30. Ann Rheum Dis

    ChatGPT vs rheumatologists: cross-sectional study on accuracy and patient perception of AI-generated information for psoriatic arthritis

    Cross-sectional studySpondyloarthritis & PsA

  31. Ann Rheum Dis

    A proteomic profile correlates with salivary gland inflammation and disease-associated antibodies in Sjögren’s disease

    Case-control studySjögren's & overlap

  32. Ann Rheum Dis

    RUNX1 is expressed in a subpopulation of dermal fibroblasts and is associated with disease severity of systemic sclerosis

    Mechanistic studySystemic sclerosis

  33. Ann Rheum Dis

    B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment

    Randomized controlled trialLupus & APS

  34. Ann Rheum Dis

    Dimerization as a key feature of autoreactive IgA antibody responses

    Mechanistic studyAcross diseases

  35. Ann Rheum Dis

    Ultrasound for assessing disease activity and structural damage in psoriatic arthritis: the UPsA scores from a multicentre study by the Italian Society of Rheumatology

    Diagnostic or prognostic studySpondyloarthritis & PsA

  36. Ann Rheum Dis

    Genome-wide association studies reveal new insights into the genetic basis of IgG4-related disease in the Chinese Han population

    Meta-analysisAutoinflammatory & rare

  37. Ann Rheum Dis

    Frequent genetic alterations in myositis autoantigen genes in cancer-associated dermatomyositis

    Mechanistic studyMyositis

  38. Ann Rheum Dis

    Cigarette smoke-primed citrullinated HLA-DR4 T cell reactivity is modulated by γδ-T cells

    Mechanistic studyRA

  39. Ann Rheum Dis

    Ultrasound-detected crystal depositions and clinical flares dissolve during successful urate-lowering therapy: 5-year follow-up results from the treat-to-target NOR-Gout study

    Cohort studyGout & crystals

  40. Ann Rheum Dis

    Clinical and biologic predictors of thrombosis in persistently antiphospholipid antibody-positive patients: Prospective analysis of the International APS ACTION Clinical Database and Repository (‘Registry’)

    Cohort studyLupus & APS

All 596 Briefs in ExploreShowing Briefs 121–160 of 596, newest first